A naukri.com initiative
Bioengineer
1w
197
Image Credit: Bioengineer
Chemotherapy Targets Neck Lymph Nodes in Ovarian Cancer
- A retrospective study published in BMC Cancer highlights the role of chemotherapy in managing isolated neck lymphatic metastasis in advanced epithelial ovarian cancer.
- The study analyzed clinical outcomes of patients with stage IV EOC and isolated NLNM, shedding light on treatment responses and survival rates.
- Patients received various treatments, with the majority undergoing neoadjuvant chemotherapy (NACT) plus interval debulking surgery (IDS).
- Surgical outcomes showed that over half of the patients achieved optimal abdominal cytoreduction through R0 resection.
- Chemotherapy exhibited efficacy in controlling neck lymph node metastases, with partial or complete remission in the majority of cases.
- Recurrence patterns revealed rare cervical lymph node relapse post-chemotherapy, supporting systemic treatment's sufficiency in managing neck nodal disease.
- Survival analysis indicated a median progression-free survival of 35 months and overall survival of 48 months for the cohort.
- Patients with R0 abdominal debulking had prolonged survival compared to those with residual disease, emphasizing the role of cytoreduction in treatment.
- The study challenges conventional approaches by suggesting that chemotherapy alone can effectively manage isolated NLNM, potentially reshaping clinical guidelines.
- The research advocates for tailored, less invasive approaches in managing advanced stage EOC with atypical metastatic patterns, emphasizing the synergy between chemotherapy and surgical cytoreduction.
Read Full Article
11 Likes
For uninterrupted reading, download the app